REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,066,000 | -59.1% | 7,500,000 | -46.4% | 0.03% | -63.0% |
Q2 2023 | $14,826,000 | +140.8% | 14,000,000 | +180.0% | 0.07% | +135.5% |
Q1 2023 | $6,157,500 | +2.6% | 5,000,000 | -23.1% | 0.03% | -29.5% |
Q4 2022 | $5,999,500 | -45.0% | 6,500,000 | -35.0% | 0.04% | -33.3% |
Q3 2022 | $10,900,000 | -0.8% | 10,000,000 | -25.9% | 0.07% | +22.2% |
Q2 2022 | $10,986,000 | -24.7% | 13,500,000 | -12.9% | 0.05% | +35.0% |
Q1 2022 | $14,580,000 | +6.5% | 15,500,000 | 0.0% | 0.04% | +73.9% |
Q4 2021 | $13,688,000 | -20.9% | 15,500,000 | +3.3% | 0.02% | -32.4% |
Q3 2021 | $17,301,000 | +18.1% | 15,000,000 | +20.0% | 0.03% | +3.0% |
Q2 2021 | $14,646,000 | +85.9% | 12,500,000 | +78.6% | 0.03% | +43.5% |
Q1 2021 | $7,880,000 | – | 7,000,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|